StonvexLoading…
StonvexCore line items from MTX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-22 | Q2 2026 2026-04-05 | Annual 2025 2025-12-31 | Q3 2025 2025-09-28 | Q2 2025 2025-06-29 |
|---|---|---|---|---|---|
Revenue | $563.96M | $546.90M | $2.07B | $1.55B | $1.02B |
Operating Income | Not available | $58.70M | $47.40M | $-14.60M | $-85.50M |
Net Income | Not available | $36.20M | $-18.40M | $-55.60M | $-98.60M |
EPS (Diluted) | $1.65 | $1.17 | $-0.59 | $-1.76 | $-3.11 |
Total Assets | Not available | $3.47B | $3.47B | $3.46B | $3.45B |
Total Liabilities | Not available | $1.70B | $1.72B | $1.75B | $1.77B |
Cash & Equivalents | Not available | $315.90M | $329.00M | $319.60M | $313.80M |
Free Cash Flow OCF − CapEx | Not available | $9.00M | $86.60M | $54.70M | $11.10M |
Shares Outstanding | Not available | 31.00M | 31.03M | 31.60M | 31.70M |